Exploring Rak tyrosine kinase function in breast cancer

Cell Cycle

Volumn 8, Issue 15, 2009, Pages 2360-2364

  Yim, Eun Kyoung ^a   Siwko, Stefan ^a   Lin, Shiaw Yih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Protein tyrosine kinase; PTEN; Rak; Tumor suppressor

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE KINASE; RAK TYROSINE KINASE; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST EPITHELIUM; CARCINOGENICITY; ENZYME STRUCTURE; HUMAN; IN VITRO STUDY; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW;

EID: 68449093415     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.15.9264     Document Type: Review

References (45)

1. Chantry A. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J Biol Chem 1995; 270:3068-3073
2. Wiesmann C, Muller YA, de Vos AM. Ligand-binding sites in Ig-like domains of receptor tyrosine kinases. J Mol Med 2000; 78:247-260 (Pubitemid 30489709)
3. Chandrasekharan S, Qiu TH, Alkharouf N, Brantley K, Mitchell JB, Liu ET. Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak. Mol Cell Biol 2002; 22:5235-5247 (Pubitemid 34700712)
4. Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem 2000; 69:373-398 (Pubitemid 30792214)
5. Tanis KQ, Veach D, Duewel HS, Bornmann WG, Koleske AJ. Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol Cell Biol 2003; 23:3884-3896 (Pubitemid 36597467)
6. Veracini L, Franco M, Boureux A, Simon V, Roche S, Benistant C. Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles. J Cell Sci 2006; 15:2921-2934 (Pubitemid 44177870)
7. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G. Structural organization of the bcr gene and its role in the Ph' translocation. Nature 1985; 315:758-761 (Pubitemid 15022931)
8. Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 1987; 84:2251-2255 (Pubitemid 17075849)
9. Cartwright CA, Meisler AI, Eckhart W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 1990; 87:558-562 (Pubitemid 20051409)
10. Meyer T, Xu L, Chang J, Liu ET, Craven RJ, Cance WG. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. Int J Cancer 2003; 104:139-146 (Pubitemid 36249787)
11. Cance WG, Craven RJ, Bergman M, Xu L, Alitalo K, Liu ET. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells. Cell Growth & Differentiation 1994; 5:1347-1355 (Pubitemid 24381523)
12. Lee J, Wang Z, Luoh SM, Wood WI, Scadden DT. Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene. Gene 1994; 138:247-251 (Pubitemid 24087586)
13. Pendergast AM. Nuclear tyrosine kinases: from Abl to WEE1. Curr Opin Cell Biol 1996; 8:174-181
14. Annerén C, Welsh M. Role of the Bsk/Iyk non-receptor tyrosine kinase for the control of growth and hormone production in RINm5F cells. Growth Factors 2000; 17:233-247 (Pubitemid 30219333)
15. Oberg-Welsh C, Welsh M. Cloning of BSK, a murine FRK homologue with a specific pattern of tissue distribution. Gene 1995; 152:239-242
16. Thuveson M, Albrecht D, Zürcher G, Andres AC, Ziemiecki A. iyk, a novel intracellular protein tyrosine kinase differentially expressed in the mouse mammary gland and intestine. Biochem Biophys Res Commun 1995; 209:582-589
17. Akerblom B, Annerén C, Welsh M. A role of FRK in regulation of embryonal pancreatic beta cell formation. Mol Cell Endocrinol 2007; 270:73-78 (Pubitemid 46670553)
18. Pories SE, Hess DT, Swenson K, Lotz M, Moussa R, Steele G Jr, et al. Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells. Gastroenterology 1998; 114:1335-1338 (Pubitemid 28243915)
19. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004; 23:7906-7909
20. Sicheri F, Kuriyan J. Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 1997; 7:777-785
21. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13:513-609.
22. Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997; 385:595-602. (Pubitemid 27087566)
23. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995; 7:176-182
24. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-330
25. Craven RJ, Cance WG, Liu ET. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb. Cancer Res 1995; 55:3969-3972
26. Yim EK, Peng G, Dai H, Hu R, Li K, Lu Y, et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 2009; 15:304-314
27. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997; 275:1943-1947 (Pubitemid 27148818)
28. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129 (Pubitemid 27247025)
29. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362 (Pubitemid 27147102)
30. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96:4240-4245
31. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000; 100:387-390 (Pubitemid 30818176)
32. Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 2001; 70:247-279 (Pubitemid 32662211)
33. Wishart MJ, Dixon JE. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Trends Cell Biol 2002; 12:579-585
34. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serinethreonine kinase containing an SH2-like region. Science 1991; 254:274-277 (Pubitemid 21917339)
35. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI3-kinase. Science 1997; 276:1848-1850 (Pubitemid 27443659)
36. Jimenez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstrom S, et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 1998; 17:743-753 (Pubitemid 28062053)
37. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 1987; 84:5034-5037
38. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppressor. Cell 2008; 133:403-414
39. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4:988-1004.
40. Brugge J, Hung MC, Mills GB. A new mutational AKTivation in the PI3K pathway. Cancer Cell 2007; 12:104-107 (Pubitemid 47199129)
41. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, et al. The integrative genomic and proteomic analysis of PIK3CA, PTEN and AKT mutations in breast cancer. Cancer Res 2008; 68:6084-6091
42. Sheng ZM, Marchetti A, Buttitta F, Champeme MH, Campani D, Bistocchi M, et al. Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer 1996; 73:144-147 (Pubitemid 26028326)
43. Becher R, Gibas Z, Sandberg AA. Chromosome 6 in malignant melanoma. Cancer Genet Cytogenet 1983; 9:173-175
44. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991; 51:5449-5453
45. Ehlen T, Dubeau L. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene 1990; 5:219-223 (Pubitemid 20095116)